140 related articles for article (PubMed ID: 16104873)
1. Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
Olesen LH; Nyvold CG; Aggerholm A; Nørgaard JM; Guldberg P; Hokland P
Eur J Haematol; 2005 Sep; 75(3):185-92. PubMed ID: 16104873
[TBL] [Abstract][Full Text] [Related]
2. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.
Christiansen DH; Pedersen-Bjergaard J
Leukemia; 2001 Dec; 15(12):1848-51. PubMed ID: 11753604
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
4. Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia.
Jamal R; Taketani T; Taki T; Bessho F; Hongo T; Hamaguchi H; Horiike S; Taniwaki M; Hanada R; Nakamura H; Hayashi Y
Genes Chromosomes Cancer; 2001 Jun; 31(2):187-90. PubMed ID: 11319806
[TBL] [Abstract][Full Text] [Related]
5. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress.
Libura M; Asnafi V; Tu A; Delabesse E; Tigaud I; Cymbalista F; Bennaceur-Griscelli A; Villarese P; Solbu G; Hagemeijer A; Beldjord K; Hermine O; Macintyre E
Blood; 2003 Sep; 102(6):2198-204. PubMed ID: 12791658
[TBL] [Abstract][Full Text] [Related]
6. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group.
Shimada A; Taki T; Tabuchi K; Taketani T; Hanada R; Tawa A; Tsuchida M; Horibe K; Tsukimoto I; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):264-9. PubMed ID: 17763464
[TBL] [Abstract][Full Text] [Related]
7. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
9. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Zorko NA; Bernot KM; Whitman SP; Siebenaler RF; Ahmed EH; Marcucci GG; Yanes DA; McConnell KK; Mao C; Kalu C; Zhang X; Jarjoura D; Dorrance AM; Heerema NA; Lee BH; Huang G; Marcucci G; Caligiuri MA
Blood; 2012 Aug; 120(5):1130-6. PubMed ID: 22674806
[TBL] [Abstract][Full Text] [Related]
10. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA
Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.
Döhner K; Tobis K; Ulrich R; Fröhling S; Benner A; Schlenk RF; Döhner H
J Clin Oncol; 2002 Aug; 20(15):3254-61. PubMed ID: 12149299
[TBL] [Abstract][Full Text] [Related]
12. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Whitman SP; Liu S; Vukosavljevic T; Rush LJ; Yu L; Liu C; Klisovic MI; Maharry K; Guimond M; Strout MP; Becknell B; Dorrance A; Klisovic RB; Plass C; Bloomfield CD; Marcucci G; Caligiuri MA
Blood; 2005 Jul; 106(1):345-52. PubMed ID: 15774615
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
[TBL] [Abstract][Full Text] [Related]
14. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
[TBL] [Abstract][Full Text] [Related]
15. FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
Chillón MC; Fernández C; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; González M; Miguel JF
Hematol J; 2004; 5(3):239-46. PubMed ID: 15167911
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF
Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839
[TBL] [Abstract][Full Text] [Related]
17. FLT3 mutations are associated with other molecular lesions in AML.
Carnicer MJ; Nomdedéu JF; Lasa A; Estivill C; Brunet S; Aventín A; Sierra J
Leuk Res; 2004 Jan; 28(1):19-23. PubMed ID: 14630076
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.
Shiah HS; Kuo YY; Tang JL; Huang SY; Yao M; Tsay W; Chen YC; Wang CH; Shen MC; Lin DT; Lin KH; Tien HF
Leukemia; 2002 Feb; 16(2):196-202. PubMed ID: 11840285
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
[TBL] [Abstract][Full Text] [Related]
20. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M
Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]